Why are you looking at Amneal Pharmaceuticals Of New York?
Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
2 agenciesRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
Agency buyer map
2 buyersRecompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Amneal Pharmaceuticals Of New York’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $827K in play. Enter a work email for two figures the page cannot show.
“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Amneal Pharmaceuticals Of New York hold?
Amneal Pharmaceuticals Of New York (UEI LVEBAQTPN615) shows $827K across 7 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Amneal Pharmaceuticals Of New York work with?
Amneal Pharmaceuticals Of New York’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (82%), Department of Defense (DOD) (18%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →